A case study on campaign integration to address an outbreak of vaccine-derived poliovirus type 2 and improve vitamin A supplementation delivery during the COVID-19 pandemic.
179 districts in 8 out of 16 regions
Mono Oral Polio Vaccine Type 2 (mOPV2) and Vitamin A Supplementation
In 2019, Ghana confirmed an outbreak of poliovirus type 2 (VDPV2) in eleven regions, necessitating an urgent vaccination campaign. This effort was challenged by the COVID-19 pandemic, which also resulted in decreased vitamin A supplementation coverage in the country. There was a need to integrate these two campaigns to address both the polio outbreak and support ongoing nutrition interventions during the pandemic. This study documented the experiences and lessons learned throughout the integration process.